Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01SQO
|
|||
| Drug Name |
Quinazoline alkaloid derivative 1
|
|||
| Synonyms |
PMID29757691-Compound-11
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H12N2O
|
|||
| Canonical SMILES |
C1CN2CC3=CC=CC=C3N=C2C1O
|
|||
| InChI |
1S/C11H12N2O/c14-10-5-6-13-7-8-3-1-2-4-9(8)12-11(10)13/h1-4,10,14H,5-7H2/t10-/m1/s1
|
|||
| InChIKey |
YIICVSCAKJMMDJ-SNVBAGLBSA-N
|
|||
| CAS Number |
CAS 18549-38-7
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:7949
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Acetylcholinesterase (AChE) | Target Info | Inhibitor | [1] |
| Cholinesterase (BCHE) | Target Info | Inhibitor | [1] | |
| Target's Patent Info | Acetylcholinesterase (AChE) | Target's Patent Info | [1] | |
| Cholinesterase (BCHE) | Target's Patent Info | [1] | ||
| KEGG Pathway | Glycerophospholipid metabolism | |||
| Cholinergic synapse | ||||
| Panther Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | ||||
| Nicotinic acetylcholine receptor signaling pathway | ||||
| Pathwhiz Pathway | Phospholipid Biosynthesis | |||
| Pathway Interaction Database | ATF-2 transcription factor network | |||
| WikiPathways | Monoamine Transport | |||
| Biogenic Amine Synthesis | ||||
| Acetylcholine Synthesis | ||||
| Integrated Pancreatic Cancer Pathway | ||||
| Irinotecan Pathway | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A patent review of butyrylcholinesterase inhibitors and reactivators 2010-2017.Expert Opin Ther Pat. 2018 Jun;28(6):455-465. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.